A Contemporary Report of Clinical Outcomes in Patients with Melanoma Brain Metastases
<i>Background:</i> Brain metastases are observed in more than 40% of all patients with stage 4 melanoma. In recent years, more extensive use of stereotactic radiation (STRT) and the advent of immune checkpoint inhibitors have positively impacted outcomes in patients with metastatic melan...
Main Authors: | William J. Phillips, Tabassom Baghai, Michael Ong, Bryan Lo, Andrea M. Ibrahim, Tyler K.T. Smith, Xinni Song |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/28/1/45 |
Similar Items
-
Real world outcomes of combination and timing of immunotherapy with radiotherapy for melanoma with brain metastases
by: Justin T. Moyers, et al.
Published: (2021-02-01) -
Stereotactic radiosurgery combined with targeted/ immunotherapy in patients with melanoma brain metastasis
by: Indrawati Hadi, et al.
Published: (2020-02-01) -
The Expanding Role of Radiosurgery for Brain Metastases
by: Mark O’Beirn, et al.
Published: (2018-08-01) -
Volumetric reduction of brain metastases after stereotactic radiotherapy: Prognostic factors and effect on local control
by: Naoyuki Kanayama, et al.
Published: (2022-12-01) -
Stereotactic Radiosurgery With Concurrent Immunotherapy in Melanoma Brain Metastases Is Feasible and Effective
by: Jakob Liermann, et al.
Published: (2020-10-01)